Skip to main content

Table 3 Age distribution and comparison between treatment groups

From: In vivo and in situ evaluation of innovative approaches in dentin hypersensitivity treatment

Descriptive statistics

PRG

Embrace

Duraphat

p-value

Mean [± SD] (years)

36.4 [± 4.8]

35.8 [± 5.8]

36.7 [± 5.5]

0.853

Median (Range) (years)

37 [28–44]

37 [26–45]

38 [27–46]

  1. * Statistically Significant at p = 0.05
  2. **Values are presented as mean [± SD] and median (range). Group comparisons were conducted using Kruskal-Wallis test to assess differences in age distribution among the treatment groups
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us